
Job-ID: 62180
Location: Wien, AUT
Job Level: Entry Level
Category: Quality
Employment Type: Temporary employment
Become part of a vital chain and contribute to our common goal of making people's lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately-owned company, where the warmth of family meets the scale of a global organisation.
With over 1600 employees, the Octapharma site in Vienna is the largest production site, and successful research and development location.
This position is temporary from 01.07.2026 until 31.08.2026 (2 months) or from 01.08.2026 until 30.09.2026 (2 months) with 38 hours per week.
We look forward to receiving your application. Please upload the following application documents: cover letter stating your desired period of employment, CV, and your high school diploma or degree certificate and a current transcript of your academic achievements.
Enjoy these attractive benefits! You can find all offers here: Benefits
The minimum gross salary according to the collective agreement (chemical industry) is EUR 2,010.75 (with high school diploma and/or over 18 years of age) based on 38 hours per week (full-time).
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application - regardless of age, gender, origin, sexual orientation, and religion.
Do you have any questions? Then get in touch with your contact person.
Mrs. Eveline Kastner (MON - THU)
Octapharma Pharmazeutika Produktionsges.m.b.H.
Oberlaaer Straße 235, 1100 Wien
T: +43 664 88 14 2750
Visit our website Octapharma Career and follow us daily on LinkedIn.
Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. With seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany, and Sweden, Octapharma also operates over 195 plasma donation centres across Europe and the US. With four decades of experience, we are committed to advancing patient care worldwide.